Published The Center for Maternal-Fetal Precision Medicine, University of California San Francisco (UCSF), will host an online international conference on Alpha Thalassemia Major (ATM), which was once considered universally fatal in utero. If left untreated, a fetus with ATM will develop severe anemia and hydrops and will die before or shortly after birth. However, recent evidence from patient registries has demonstrated that when ATM is diagnosed early in pregnancy, in utero transfusions (IUT) can reverse hydrops and enable survival with good neurological outcomes. For more information and registration, please visit: https://mfprecision.ucsf.edu/2020/11/01/virtual-conference-on-alpha-thalassemia-major/
To download the conference program, please click >>here<<
